Amy C. Moore: Global biomarker testing survey focused on patients and caregivers diagnosed with NSCLC
Amy C. Moore shared post by Precision Oncology Connect on X:
“For those attending ESMO24, be sure to check out our poster on our global biomarker testing survey focused on patients and caregivers diagnosed with NSCLC in the past 5 years by Dr. Antonio Calles, Christian Rolfo, Shani Shilo, Dr Anne-Marie Baird, Abdelali (Ali) Majdi and Bayer AG.”
Quoting Precision Oncology Connect’s post:
“Visit this poster at ESMO24 ‘Assessing Biomarker Testing Awareness Among Patients and Caregivers in NSCLC Through an Interdisciplinary Global Survey’ 204p.
- Sunday 15th Sept
- 12.00-13.00h
- CEST, Hall 6.”
Source: Amy C. Moore/X and Precision Oncology Connect/X
Dr. Amy C. Moore is the Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation. She previously served as the Director of Science & Research at the Addario Lung Cancer Medical Institute (ALCMI). She has published peer-reviewed papers on virology, cancer, and biomarker testing in NSCLC. Dr. Moore is also an expert on COVID-19’s impact on lung cancer and serves on several advisory boards.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023